Staphylococcal Infection Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: SA9267B652A9EN
Market Monitor Global

Abstracts

A drug used to treat infections caused by staphylococci

This report contains market size and forecasts of Staphylococcal Infection Treatment in Global, including the following market information:

Global Staphylococcal Infection Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Staphylococcal Infection Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Staphylococcal Infection Treatment include Nymox Pharmaceutical, Evolva, Destiny Pharma, Viral Genetics, Sequoia Sciences and TAXIS Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Staphylococcal Infection Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Staphylococcal Infection Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Staphylococcal Infection Treatment Market Segment Percentages, by Type, 2021 (%)

• Oral Medication
• Injection Liquid

Global Staphylococcal Infection Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Staphylococcal Infection Treatment Market Segment Percentages, by Application, 2021 (%)

• Staphylococcus Aureus Infection
• Staphylococcus Epidermis Infection
• Saprococcus Infection

Global Staphylococcal Infection Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Staphylococcal Infection Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Staphylococcal Infection Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Staphylococcal Infection Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Nymox Pharmaceutical
• Evolva
• Destiny Pharma
• Viral Genetics
• Sequoia Sciences
• TAXIS Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Staphylococcal Infection Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Staphylococcal Infection Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL STAPHYLOCOCCAL INFECTION TREATMENT OVERALL MARKET SIZE

2.1 Global Staphylococcal Infection Treatment Market Size: 2021 VS 2028
2.2 Global Staphylococcal Infection Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Staphylococcal Infection Treatment Players in Global Market
3.2 Top Global Staphylococcal Infection Treatment Companies Ranked by Revenue
3.3 Global Staphylococcal Infection Treatment Revenue by Companies
3.4 Top 3 and Top 5 Staphylococcal Infection Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Staphylococcal Infection Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Staphylococcal Infection Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Staphylococcal Infection Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Staphylococcal Infection Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Staphylococcal Infection Treatment Market Size Markets, 2021 & 2028
  4.1.2 Oral Medication
  4.1.3 Injection Liquid
4.2 By Type - Global Staphylococcal Infection Treatment Revenue & Forecasts
  4.2.1 By Type - Global Staphylococcal Infection Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Staphylococcal Infection Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Staphylococcal Infection Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Staphylococcal Infection Treatment Market Size, 2021 & 2028
  5.1.2 Staphylococcus Aureus Infection
  5.1.3 Staphylococcus Epidermis Infection
  5.1.4 Saprococcus Infection
5.2 By Application - Global Staphylococcal Infection Treatment Revenue & Forecasts
  5.2.1 By Application - Global Staphylococcal Infection Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Staphylococcal Infection Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Staphylococcal Infection Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Staphylococcal Infection Treatment Market Size, 2021 & 2028
6.2 By Region - Global Staphylococcal Infection Treatment Revenue & Forecasts
  6.2.1 By Region - Global Staphylococcal Infection Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Staphylococcal Infection Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Staphylococcal Infection Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Staphylococcal Infection Treatment Revenue, 2017-2028
  6.3.2 US Staphylococcal Infection Treatment Market Size, 2017-2028
  6.3.3 Canada Staphylococcal Infection Treatment Market Size, 2017-2028
  6.3.4 Mexico Staphylococcal Infection Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Staphylococcal Infection Treatment Revenue, 2017-2028
  6.4.2 Germany Staphylococcal Infection Treatment Market Size, 2017-2028
  6.4.3 France Staphylococcal Infection Treatment Market Size, 2017-2028
  6.4.4 U.K. Staphylococcal Infection Treatment Market Size, 2017-2028
  6.4.5 Italy Staphylococcal Infection Treatment Market Size, 2017-2028
  6.4.6 Russia Staphylococcal Infection Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Staphylococcal Infection Treatment Market Size, 2017-2028
  6.4.8 Benelux Staphylococcal Infection Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Staphylococcal Infection Treatment Revenue, 2017-2028
  6.5.2 China Staphylococcal Infection Treatment Market Size, 2017-2028
  6.5.3 Japan Staphylococcal Infection Treatment Market Size, 2017-2028
  6.5.4 South Korea Staphylococcal Infection Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Staphylococcal Infection Treatment Market Size, 2017-2028
  6.5.6 India Staphylococcal Infection Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Staphylococcal Infection Treatment Revenue, 2017-2028
  6.6.2 Brazil Staphylococcal Infection Treatment Market Size, 2017-2028
  6.6.3 Argentina Staphylococcal Infection Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Staphylococcal Infection Treatment Revenue, 2017-2028
  6.7.2 Turkey Staphylococcal Infection Treatment Market Size, 2017-2028
  6.7.3 Israel Staphylococcal Infection Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Staphylococcal Infection Treatment Market Size, 2017-2028
  6.7.5 UAE Staphylococcal Infection Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Nymox Pharmaceutical
  7.1.1 Nymox Pharmaceutical Corporate Summary
  7.1.2 Nymox Pharmaceutical Business Overview
  7.1.3 Nymox Pharmaceutical Staphylococcal Infection Treatment Major Product Offerings
  7.1.4 Nymox Pharmaceutical Staphylococcal Infection Treatment Revenue in Global Market (2017-2022)
  7.1.5 Nymox Pharmaceutical Key News
7.2 Evolva
  7.2.1 Evolva Corporate Summary
  7.2.2 Evolva Business Overview
  7.2.3 Evolva Staphylococcal Infection Treatment Major Product Offerings
  7.2.4 Evolva Staphylococcal Infection Treatment Revenue in Global Market (2017-2022)
  7.2.5 Evolva Key News
7.3 Destiny Pharma
  7.3.1 Destiny Pharma Corporate Summary
  7.3.2 Destiny Pharma Business Overview
  7.3.3 Destiny Pharma Staphylococcal Infection Treatment Major Product Offerings
  7.3.4 Destiny Pharma Staphylococcal Infection Treatment Revenue in Global Market (2017-2022)
  7.3.5 Destiny Pharma Key News
7.4 Viral Genetics
  7.4.1 Viral Genetics Corporate Summary
  7.4.2 Viral Genetics Business Overview
  7.4.3 Viral Genetics Staphylococcal Infection Treatment Major Product Offerings
  7.4.4 Viral Genetics Staphylococcal Infection Treatment Revenue in Global Market (2017-2022)
  7.4.5 Viral Genetics Key News
7.5 Sequoia Sciences
  7.5.1 Sequoia Sciences Corporate Summary
  7.5.2 Sequoia Sciences Business Overview
  7.5.3 Sequoia Sciences Staphylococcal Infection Treatment Major Product Offerings
  7.5.4 Sequoia Sciences Staphylococcal Infection Treatment Revenue in Global Market (2017-2022)
  7.5.5 Sequoia Sciences Key News
7.6 TAXIS Pharmaceuticals
  7.6.1 TAXIS Pharmaceuticals Corporate Summary
  7.6.2 TAXIS Pharmaceuticals Business Overview
  7.6.3 TAXIS Pharmaceuticals Staphylococcal Infection Treatment Major Product Offerings
  7.6.4 TAXIS Pharmaceuticals Staphylococcal Infection Treatment Revenue in Global Market (2017-2022)
  7.6.5 TAXIS Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Staphylococcal Infection Treatment Market Opportunities & Trends in Global Market
Table 2. Staphylococcal Infection Treatment Market Drivers in Global Market
Table 3. Staphylococcal Infection Treatment Market Restraints in Global Market
Table 4. Key Players of Staphylococcal Infection Treatment in Global Market
Table 5. Top Staphylococcal Infection Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Staphylococcal Infection Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Staphylococcal Infection Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Staphylococcal Infection Treatment Product Type
Table 9. List of Global Tier 1 Staphylococcal Infection Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Staphylococcal Infection Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Staphylococcal Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Staphylococcal Infection Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Staphylococcal Infection Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Staphylococcal Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Staphylococcal Infection Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Staphylococcal Infection Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Staphylococcal Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Staphylococcal Infection Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Staphylococcal Infection Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Staphylococcal Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Staphylococcal Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Staphylococcal Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Staphylococcal Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Staphylococcal Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Nymox Pharmaceutical Corporate Summary
Table 31. Nymox Pharmaceutical Staphylococcal Infection Treatment Product Offerings
Table 32. Nymox Pharmaceutical Staphylococcal Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Evolva Corporate Summary
Table 34. Evolva Staphylococcal Infection Treatment Product Offerings
Table 35. Evolva Staphylococcal Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Destiny Pharma Corporate Summary
Table 37. Destiny Pharma Staphylococcal Infection Treatment Product Offerings
Table 38. Destiny Pharma Staphylococcal Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Viral Genetics Corporate Summary
Table 40. Viral Genetics Staphylococcal Infection Treatment Product Offerings
Table 41. Viral Genetics Staphylococcal Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Sequoia Sciences Corporate Summary
Table 43. Sequoia Sciences Staphylococcal Infection Treatment Product Offerings
Table 44. Sequoia Sciences Staphylococcal Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 45. TAXIS Pharmaceuticals Corporate Summary
Table 46. TAXIS Pharmaceuticals Staphylococcal Infection Treatment Product Offerings
Table 47. TAXIS Pharmaceuticals Staphylococcal Infection Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Staphylococcal Infection Treatment Segment by Type in 2021
Figure 2. Staphylococcal Infection Treatment Segment by Application in 2021
Figure 3. Global Staphylococcal Infection Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Staphylococcal Infection Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Staphylococcal Infection Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Staphylococcal Infection Treatment Revenue in 2021
Figure 8. By Type - Global Staphylococcal Infection Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Staphylococcal Infection Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Staphylococcal Infection Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Staphylococcal Infection Treatment Revenue Market Share, 2017-2028
Figure 12. US Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Staphylococcal Infection Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Staphylococcal Infection Treatment Revenue Market Share, 2017-2028
Figure 24. China Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Staphylococcal Infection Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Staphylococcal Infection Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Staphylococcal Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Nymox Pharmaceutical Staphylococcal Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Evolva Staphylococcal Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Destiny Pharma Staphylococcal Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Viral Genetics Staphylococcal Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sequoia Sciences Staphylococcal Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. TAXIS Pharmaceuticals Staphylococcal Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)